BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37223682)

  • 1. Optimal
    Zuo Y; Liu Q; Li N; Li P; Zhang J; Song S
    Front Oncol; 2023; 13():1173355. PubMed ID: 37223682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of multi-center
    Zuo Y; Liu L; Chang C; Yan H; Wang L; Sun D; Ruan M; Lei B; Xia X; Xie W; Song S; Huang G
    Med Phys; 2024 Jan; ():. PubMed ID: 38285641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting EGFR mutation subtypes in lung adenocarcinoma using
    Liu Q; Sun D; Li N; Kim J; Feng D; Huang G; Wang L; Song S
    Transl Lung Cancer Res; 2020 Jun; 9(3):549-562. PubMed ID: 32676319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of radiomics based on
    Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of
    Li S; Li Y; Zhao M; Wang P; Xin J
    Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs.
    Yang L; Xu P; Li M; Wang M; Peng M; Zhang Y; Wu T; Chu W; Wang K; Meng H; Zhang L
    Front Oncol; 2022; 12():894323. PubMed ID: 35800046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of
    Zhang M; Bao Y; Rui W; Shangguan C; Liu J; Xu J; Lin X; Zhang M; Huang X; Zhou Y; Qu Q; Meng H; Qian D; Li B
    Front Oncol; 2020; 10():568857. PubMed ID: 33134170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
    Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
    Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of [
    Gao J; Niu R; Shi Y; Shao X; Jiang Z; Ge X; Wang Y; Shao X
    EJNMMI Res; 2023 Apr; 13(1):26. PubMed ID: 37014500
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yang B; Ji HS; Zhou CS; Dong H; Ma L; Ge YQ; Zhu CH; Tian JH; Zhang LJ; Zhu H; Lu GM
    Transl Lung Cancer Res; 2020 Jun; 9(3):563-574. PubMed ID: 32676320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of EGFR mutation status in lung adenocarcinoma based on
    Tan JL; Xia L; Sun SG; Zeng H; Lu DY; Cheng XJ
    Am J Nucl Med Mol Imaging; 2023; 13(5):230-244. PubMed ID: 38023818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on
    Koyasu S; Nishio M; Isoda H; Nakamoto Y; Togashi K
    Ann Nucl Med; 2020 Jan; 34(1):49-57. PubMed ID: 31659591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Contrasted CT Radiomics for SAH Prognosis Prediction.
    Shan D; Wang J; Qi P; Lu J; Wang D
    Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing radiomics model in clinical translation.
    Cheng B; Deng H; Zhao Y; Xiong J; Liang P; Li C; Liang H; Shi J; Li J; Xiong S; Lai T; Chen Z; Wu J; Qian T; Huan W; Ng MTA; He J; Liang W
    Eur Radiol; 2022 Sep; 32(9):5869-5879. PubMed ID: 35348863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI-Based Radiomics Approaches for Preoperative Prediction of EGFR Mutation Status in Spinal Bone Metastases in Patients with Lung Adenocarcinoma.
    Jiang X; Ren M; Shuang X; Yang H; Shi D; Lai Q; Dong Y
    J Magn Reson Imaging; 2021 Aug; 54(2):497-507. PubMed ID: 33638577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging phenotyping using
    Zhou L; Sun J; Long H; Zhou W; Xia R; Luo Y; Fang J; Wang Y; Chen X
    Insights Imaging; 2024 Jan; 15(1):5. PubMed ID: 38185779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting
    Zhang G; Cao Y; Zhang J; Ren J; Zhao Z; Zhang X; Li S; Deng L; Zhou J
    Am J Cancer Res; 2021; 11(2):546-560. PubMed ID: 33575086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.